Labiana Health Sa · BME:LAB
Labiana Health Sa — Investor Presentation (October 2026)
66 slides from Labiana Health Sa's investor presentation, October 2026
Slide 1: Company Profile
Company Profile LAB_CorporatePresentation_Oct2026
Slide 2: Table of Contents
Table of Contents COMPANY OVERVIEW LABIANA SERVICES CMO & CDMO Regulatory Affairs In-Licensing & R&D Out-Licensing Select a section to navigate directly to the relevant page
Slide 3: Company Overview
Company Overview Return to Table of Contents
Slide 4: Labiana at a Glance
Labiana at a Glance A globally integrated Animal and Human Health company with EU-GMP manufacturing capabilities, a diversified portfolio of proprietary and third-party products, and a strong international footprint built through long-standing partnerships. 380+ 656 MAs 2 employees worldwide EU-GMP
Slide 5: Two-Division Overview
Two-Division Overview Animal Health Human Health 1 Manufacturing site CDMO/CMO services 1 Manufacturing site CDMO/CMO services (EU-GMP) Licensing in/out (EU-GMP) Licensing in/out Terrassa, Spain services Corbera de Llobregat, Spain services Animal Health division with 50+ proprietary brands, a globa
Slide 6: Global presence
Global presence % Turnover geographic distribution in 2025 Turkey Commercial office Spain Headquarters 2 Manufacturing site Mexico Commercial office Ecuador Commercial office Spain 29.2% EU ex-Spain 56.5% North America 6.6% Rest of the world 7.8% Present in 156+ countries through our commercial netw
Slide 7: Key Milestones
Key Milestones LABIANA HEALTH 1958 1999 2004 2019 2022 2026 Manufacturing Listed on BME Lyophilization Labiana founded Management Buy-Out International growth capacity expansion expansion Growth as an Animal Health Incorporation of Labiana Zoleant acquisition in Installation of two new nutrition com
Slide 8: Partners
Partners Human Health Animal Health A trusted partner to leading global pharmaceutical companies
Slide 9: Investee Companies
Investee Companies Founded in 1912, the company specializes in the formulation and manufacturing of viral and bacterial vaccines, medicines, and nutritional products. https://www.vetzavod.com/en/index.php LABIANA CONTRIBUTION: 10% ownership Supporting international market expansion and fostering str
Slide 10: CDMO/CMO Services
CDMO/CMO Services Return to Table of Contents
Slide 11: Value Proposition
Value Proposition Specialized manufacturing partner for complex and regulated pharmaceutical projects: Labiana is a trusted CDMO/CMO partner for human and animal health, with proven experience across more than 40 therapeutic areas We specialize in complex sterile products, including liquid and lyoph
Slide 12: Business Expertise as CDMO/CMO
Business Expertise as CDMO/CMO PHARMACEUTICAL DEVELOPMENT In-house formulation and galenic development, from laboratory to validation batches, ensuring robust products ready for industrialization GLOBAL SUPPLY & DISTRIBUTION ANALYTICAL DEVELOPMENT & Proven international supply and distribution of QU
Slide 13: Product Development Roadmap Services as a Trusted CDMO/CMO Partner
Product Development Roadmap Services as a Trusted CDMO/CMO Partner GALENIC DEVELOPMENT ANALYTICAL DEVELOPMENT REGULATORY AFFAIRS RRAA Formulation development & AQbD analytical development & Dossier due diligence & gap QbD-driven development validation analysis Process development and tech Stability
Slide 14: Therapeutic Areas
Therapeutic Areas Human health Animal health Allergy & Respiratory Anti-infectives & Parasitology Analgesia, Anaesthesia & Inflammation Central Nervous System Anti-infectives & Antisepsis Endocrine & Metabolic Cardiovascular Nutrition & Supplements Central Nervous System Pain & Anaesthesia Endocrine
Slide 15: Animal Health Molecule Expertise
Animal Health Molecule Expertise ANTHESTETICS LIDOCAINE ACETYLSALYCYLIC ACID MELOXICAM CHLORAMPHENICOL MICONAZOLE NITRATE NSAIDS FLUNIXIN MEGLUMINE METAMIZOLE SODIUM KETOPROFEN TOLFENAMIC ACID COLISTIN SULPHATE OXYTETRACYCLINE DIHYDRATE DIHYDROSTREPTOMYCIN SULPHATE OXYTETRACYCLINE HYDROCHLORIDE OPIO
Slide 16: Human Health Molecule Expertise
Human Health Molecule Expertise PYRIDOXINE HYDROCHLORIDE + ALLERGY & CYCLIZINE DOXYLAMINE SUCCINATE EMPAGLIFLOZINE OCTREOTIDE ACETATE IMMUNOLOGY HISTAMINE HYDROCHLORIDE ENDOCRINE & FOLLICLE-STIMULATING LUTEINIZING HORMONE (LH) HORMONE (FSH) METABOLIC DISORDERS OXICODONE / NALOXONE TRAMADOL HYDROCHLO
Slide 17: Capabilities of each manufacturing site
Capabilities of each manufacturing site LABIANA PHARMACEUTICALS Human Health LABIANA LIFE SCIENCES Animal Health Select a section to navigate directly to the relevant page Return to Table of Contents
Slide 18: Manufacturing Site
Manufacturing Site Corbera de Llobregat (Barcelona) Manufacturing site, 8000 m2 Return to Table of Contents
Slide 19: Capabilities
Capabilities Authorised Manufacturing Capabilities Aseptically Solids processed Capsules Tablets Granules / Powders NON STERILE STERILE Terminally Liquids sterilized CERTIFICATIONS Psychotropic and narcotic drugs Hormone products Clinical Studies Select a section to navigate directly to the relevant
Slide 20: Authorised Manufacturing Capabilities
Authorised Manufacturing Capabilities Sterile Area Packaging Capabilities Aseptically processed Lyophilised ampoules & vials Form: Ampoules Liquid ampoules & vials Format: 1-10 mL Batch:10-1.000 L Terminally sterilised Form: Glass vials Format: 1-50 mL Liquid ampoules & vials Batch:10-300 L
Slide 21: Authorised Manufacturing Capabilities
Authorised Manufacturing Capabilities Lyophilizated We have 2 lyophilisers (Lyofast 20) 20.5 m² chamber capacity per unit Automatic loading Integrated CIP/SIP systems Packaging Capabilities Form: Freeze-dried vials Form: Freeze-dried ampoules Format: 1-50 mL Format: 1-10 mL Batch: 10-300 L Batch: 10
Slide 22: Authorised Manufacturing Capabilities
Authorised Manufacturing Capabilities Non-Sterile Area Packaging Capabilities Solids Hard gelatin capsules Form: Sachets Tablets Format: 2-50 g Batch: 30-400 Kg Film-coated tablets Sugar-coated tablets Granules / Powders Form: Blisters Format: PVC/Alu, PVDC/Alu, Alu/Alu Presentation: pre-cuted blist
Slide 23: Manufacturing Site
Manufacturing Site Terrassa (Barcelona) Manufacturing site, 9000 m2 Return to Table of Contents
Slide 24: Capabilities
Capabilities Authorised Manufacturing Capabilities Aseptically Solids processed Powders NON STERILE STERILE Terminally sterilized Liquids Liquids for internal & external use CERTIFICATIONS Sterile products Psychotropic & narcotic drugs Hormonal products Non-sterile liquids Select a section to naviga
Slide 25: Authorised Manufacturing Capabilities
Authorised Manufacturing Capabilities Sterile Area Packaging Capabilities Form: Plastic Aseptically processed Format: 10-500 mL Batch:100-2000 L Solutions / Suspensions Vials (glass & plastic) & Eyedrops Form: Glass Vials Format: 5-250 mL Batch:100-2000 L Terminally sterilised Solutions / Suspension
Slide 26: Authorised Manufacturing Capabilities
Authorised Manufacturing Capabilities Non-Sterile Area Packaging Capabilities Form: Sachets Format: 0,500 - 1 Kg Batch: 500 Kg Form: Jars & Drums Format: 5 L Solids Batch: 1000-5000 L Powders Form: Plastic bottles Format: 250 mL - 1L Batch: 1000-5000 L Liquids Oral Solution & Suspensions Form: Plast
Slide 27: Why partner with Labiana as your CDMO/CMO
Why partner with Labiana as your CDMO/CMO Labiana delivers complex CDMO projects with industrial reliability and regulatory confidence Long-term partner for human and animal health Dual know-how supporting scalable, sustainable collaborations across the full product lifecycle One end-to-end CDMO/CMO
Slide 28: Product Portfolio
Product Portfolio Return to Table of Contents
Slide 29: Product portfolio
Product porfolio LABIANA PHARMACEUTICALS Human Health LABIANA LIFE SCIENCES Animal Health Select a section to navigate directly to the relevant page Return to Table of Contents
Slide 30: Human Health Product Portfolio
Human Health Product Portfolio Corbera de Llobregat (Barcelona) Manufacturing site, 8000 m2 Return to Table of Contents
Slide 31: Human Health Product portfolio: Ethical Products
Human Health Product porfolio Ethical Products Fosfomycin Trometamol 3g Oral Solution | Granules in sachets Fosfomycin Sodium 2g & 4g Powder for solution for infusion Octreotide 0.1mg/ml & 0.5mg/ml Solution for injection & infusion Ondansetron 2mg/ml Solution for injection & infusion Empagliflozin 1
Slide 32: Fosfomycin Trometamol 3g
Fosfomycin Trometamol 3g Oral solution | Granules in sachets Fosfomycin Trometamol 3g is indicated for the treatment of uncomplicated acute cystitis in adult women and adolescents for 12 years.1 It is a broad antibacterial spectrum, covering the most frequent Gram-positive and Gram-negative urinary
Slide 33: Fosfomycin Trometamol 3g: Why Labiana as a Partner?
Fosfomycin Trometamol 3g Why Labiana as a Partner? Long-standing expertise in Fosfomycin development Fully vertically integrated: from API to finished dosage form¹ Commitment to quality: Manufactured in EU-GMP certified, PIC/S inspected facility Holders of a generic CTD dossier with multiple Marketi
Slide 34: Fosfomycin Sodium 2g & 4g
Fosfomycin Sodium 2g & 4g Broad-Spectrum Injectable Antibiotic Fosfomycin is a broad-spectrum, bactericidal antibiotic with a low molecular weight, active against multidrug-resistant Gram-negative bacteria. Acts by irreversibly inhibiting bacterial cell wall synthesis at an early stage. For intraven
Slide 35: Fosfomycin Sodium 2g & 4g: Why Labiana as a Partner?
Fosfomycin Sodium 2g & 4g Why Labiana as a Partner? Vertical integration: from development to commercialisation Unique antibiotic in its therapeutic class Our 15+ years of expertise in Fosfomycin Trometamol manufacturing position us as a trusted partner for high-quality Fosfomycin Sodium solutions N
Slide 36: Octreotide 0.1mg/ml & 0.5mg/ml
Octreotide 0.1mg/ml & 0.5mg/ml Solution for injection and infusion Octreotide is indicated for the control and relief of symptoms associated with: Acromegaly: Reduces Growth Hormone and Insulin-like growth factor to near-normal levels The prevention of complications after pancreatic surgery The trea
Slide 37: Octreotide: Why Labiana as a Partner?
Octreotide 0.1mg/ml & 0.5mg/ml Why Labiana as a Partner? Vertical integration: from development to commercialisation Patent-free: open to commercialization Hospital-focused product with a ready-to-submit EU dossier Presentation: Originator: Solution for injection | pack of 5 ampoules of 0.1 mg/ml or
Slide 38: Ondansetron 2mg/ml
Ondansetron 2mg/ml Solution for injection/infusion Ondansetron is a potent, highly selective 5HT3 receptor antagonist Indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, prevention of treatment of post-operative nausea and vomiting (PONV) Administe
Slide 39: Ondansetron: Why Labiana as a Partner?
Ondansetron 2mg/ml Why Labiana as a Partner? Vertical integration: from development to commercialisation Antiemetic treatment: addressing supportive care needs in oncology and emetogenic treatments Proven track record of compliance with GMP standards and international regulations Presentation: Origi
Slide 40: Empagliflozin 10mg & 25mg
Empagliflozin 10mg & 25mg Film-coated tablets Empagliflozin is a selective competitive inhibitor of sodium-glucose co-transporter-2 (SGLT 2) It prevents the reabsorption of glucose through the renal tubule, thus promoting its elimination through the urine thereby lowering blood glucose levels¹ SGLT2
Slide 41: Empagliflozin: Why Labiana as a Partner?
Empagliflozin 10mg & 25mg Why Labiana as a Partner? Vertical integration: from development to commercialisation Proven track record of compliance with GMP standards and international regulations Our empagliflozin product is BCS* Class III, biowaiver eligible reducing development timelines and enabli
Slide 42: Human Health Product portfolio: Non-Prescribed Products
Human Health Product porfolio Non-Prescribed Products Precyst® Natural Prevention for Recurrent UTIs Vitalgest® Complete Maternal & Fetal nutritional support Return to Ethical Select a section to navigate directly to the relevant page Move to Under Products Development Products
Slide 43: Precyst®
Precyst® Natural Prevention for Recurrent Urinary Tract Infection (UTIs) Precyst® is a food supplement combining D-mannose and cranberry extract (PACs) to to support urinary tract health and prevent cystitis in women¹ Uses Designed for women looking to support their urinary tract health as part of t
Slide 44: Vitalgest®
Vitalgest® Complete maternal & fetal nutritional support Vitalgest® is a gold standard prenatal supplement combining essential vitamins, minerals, fatty acids and functional bioactives designed to meet the increased nutritional needs of pregnancy, supporting both the mother and the foetus¹ Uses Nutr
Slide 45: Vitalgest®
Vitalgest® Complete maternal & fetal nutritional support Target customer: Women planning a pregnancy or currently pregnant Point of sale: Pharmacies No prescription needed | Rx recommendation Presentation: 60 capsules per pack 30 soft gel capsules | 30 hard delayed-release capsules Recommended dose:
Slide 46: Human Health Product portfolio: Under Development Products
Human Health Product porfolio Under Development Products Prevention and reduction of stretch marks Woman health care Antifungal with improved absorption Woman health care Menopause and perimenopause women Woman health care Treatment of erectile dysfunction (Galenic innovation) Genitourinary Select a
Slide 47: What's Next?
What’s Next? Indication Therapeutical Area Designation Status Prevention and reduction of stretch marks Woman health care Non-prescribed product Under development Antifungal with improved absorption Woman health care Ethical Products Under development Menopause and perimenopause women Woman health c
Slide 48: Animal Health Product Portfolio
Animal Health Product Portfolio Terrassa (Barcelona) Manufacturing site, 9000 m2 Return to Table of Contents
Slide 49: Top Best-Selling Products
Top 6 Best-Selling Products Labimycin Labiprofen Aquachok Oxytetracycline 300 mg/ml Ketoprofen 150 mg/ml Vitamins & Amino Acids Broad-spectrum antibiotic Anti-inflammatory & analgesic Stress recovery support Cattle • Sheep • Swine Cattle • Swine • Horses Livestock • Poultry Tilolab Tolfelab Buprelab
Slide 50: Product Portfolio
Product Porfolio Antibiotics Anti-inflammatories Anaesthesia /Analgesia Surgery / Wound Nutritional Metabolism regulators Treatment Vitamins Select a section to navigate directly to the relevant page
Slide 51: Antibiotics
Antibiotics Estreptolab Gentasol Kin-O-Flox Labimycin® LA Labixxin Dihydrostreptomycin sulfate 250 Gentamicin sulfate 80,000 IU/ml Enrofloxacin 100 mg/ml Oxytetracycline dihydrate 300 Tulathromicin 100 mg/ml mg/ml mg/ml Linco-Res Lincomycin hydrochloride (50 mg): 45.9 Lincolab® mg/ml of lincomycin /
Slide 52: Anti-inflammatories
Anti-inflammatories KetoProPig® Labiprofen Tolfelab Ketoprofen 100 mg/ml Ketoprofen 150 mg/ml Tolfenamic acid 40mg/ml Return to Product Portfolio
Slide 53: Anaesthesia / Analgesia
Anaesthesia / Analgesia Aceprolab Buprelab Equipromazina Acepromazine maleate 5mg/ml Buprenorphine 0.3mg/ml Acepromazine maleate 5mg/ml Return to Product Portfolio
Slide 54: Surgery / Wound Treatment
Surgery / Wound Treatment Zincalab® Fish oil (source of vitamins A and D), vitamin E, zinc oxide, titanium dioxide, bergamot essential oil, evening primrose oil (source of essential fatty acids). Return to Product Portfolio
Slide 55: Nutritional
Nutritional Apivit Aqualyte Bromint Plus Farmalac® Glucomin Hepafort Hepamet® Liver Protector Plus Rumilab® Return to Product Portfolio
Slide 56: Metabolism regulators
Metabolism regulators Labiana Injectable Calcium Gleptoferron Labiana Rumintral/Neoskilab Calcium gluconate Magnesium chloride hexahydrate Magnesium Gleptoferron 532.6 mg/ml Neostigmine methylsulfate 1.5 mg/ml hypophosphite hexahydrate Return to Product Portfolio
Slide 57: Vitamins
Vitamins Aquachok® Aminovit Plus, Aminovit Oral, Glucovit C Labhidro®AD3E Labidrosol® B Amino Aquachok Amino premix Labhidro AD3E, Labhidro AD3E+C, Labiana ADEKC, Labiana E-Sel Plus Labiana Lyso Plus Nov-A-Vit Nov-E-Sel / E-Selensol Aquavit B Labiatonic Return to Product Move to the end Portfolio
Slide 58: Regulatory Affairs
Regulatory Affairs Return to Table of Contents
Slide 59: Regulatory Affairs services
Regulatory Affairs services Regulatory Affairs services Pilot Plant Equipment Regulatory support for out-licensing and CDMO projects Pharmacovigilance services: Regulatory strategy EU QPPV / National QPPV in Spain Dossier due diligence Individual Case Safety Report (ICSR) Gap analyses: assessment of
Slide 60: Research & Development
Research & Development Return to Table of Contents
Slide 61: Research & Development: Galenic Development
Research & Development Galenic Development Galenic Development Pilot Plant Equipment Tableting machine (25 punches station, eccentric machine) Pre-formulation and formulation: V-shape bin Complete pharmaceutical development for Sieving machine dossier submission Granulation machine (5L) Development
Slide 62: Research & Development: Analytical Development
Research & Development Analytical Development Analytical Development Pilot Plant Equipment HPLC (Agilent):10 equipment,UV detector and refractive index detector Development of analytical methods Gas chromatography (Agilent) 2 equipment: FID and TCD detector AQbD: analytical quality by design Forced
Slide 63: R&D Pipeline
R&D Pipeline New products accumulated in the pipeline 14 17 G: Generic 13 I: Innovative OTC: Over-The-Counter 9 8 5 2 2021 2022 2023 2024 2026 2028 2029 Non-Immune Biologic Buprelab 0.3 mg/ml Labymicin LA 300 Tolfelab 40 mg/ml (G) Calciolab 216.18 / Anti-inflammatory (I) (G) mg/ml (G) Labixxin 100 m
Slide 64: R&D Benchmarks
R&D Benchmarks Strategic collaborations with leading academic and research institutions supporting innovation, analytical excellence, and product development.
Slide 65: R&D Projects & Opportunities for B2B Partnerships
R&D Projects & Opportunities for B2B Partnerships Proprietary 1 API under development 2 Approved dossiers 2 generic products Fosfomycin Sodium Empagliflozin & Octreotide Under development in Human Health (Fosfomycin EU MAs available Sodium & Ondansetron) Dossiers ready for Open to B2B partnerships s
Slide 66: Contact us
Contact us C/ Venus, 26 | 08228 Terrassa (Barcelona) C/ Casanova, 27-31 | 08757 Corbera de Tel: (+34) 93 736 97 00 Llobregat (Barcelona) E-mail: info@labiana.com Tel: (+34) 93 688 29 00 E-mail: info@labiana.com
Labiana Health — Investor Presentation (October 2026) on 6ix